Prolastin-C (Alpha1-proteinase inhibitor [human]) for COPD | MyCOPDTeam

Connect with others who understand.

sign up Log in
About MyCOPDTeam
Powered By

Prolastin-C is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin (AAT) deficiency, a rare genetic condition. Prolastin-C is also known by its drug name, alpha1-proteinase inhibitor [human].

Prolastin-C is an alpha1-proteinase inhibitor, a type of molecule derived from human plasma. Prolastin-C is believed to work by protecting the lungs from damage.

How do I take it?
Prolastin-C is administered once a week as an intravenous infusion.

Prolastin-C comes in vial form and requires reconstitution.

Side effects
The FDA-approved label for Prolastin-C lists common side effects including upper respiratory tract infections.

Rare but serious side effects listed for Prolastin-C can include the potential risk for transmitting infectious agents such as viruses.



Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in